Dr. Danica Stanimirovic receives Public Service Excellence Award and Fellowship to the Canadian Academy of Health Sciences

- Ottawa, OntarioCanada

Dr. Danica Stanimirovic

Congratulations to Dr. Danica Stanimirovic for receiving the Public Service Award of Excellence. This award recognizes her work as a neuroscientist and research director at the National Research Council of Canada (NRC). It also recognizes public servants who are innovative, highly skilled and collaborative. Recipients maintain strong ethics in their day-to-day work, and inspire and motivate others through their professionalism.

Dr. Stanimirovic, Director of R&D, Translational Bioscience Department and Production Platforms & Analytics Department with our Human Health Therapeutics Research Centre, also recently became a Fellow of the Canadian Academy of Health Sciences. This designation, recognized by her peers nationally and internationally, recognizes her contributions to the promotion of health science. As a Fellow, she embodies leadership, creativity, distinctive competencies and background, and a commitment to advance academic health science.

Dr. Stanimirovic's research has focused on developing technologies to overcome the blood brain barrier to treat such neurological diseases as brain cancer, Alzheimer's and dementia. She has revolutionized the scientific community's understanding of brain function and diseases and helped make the NRC a renowned research facility for neuroscience and the blood-brain barrier.

Throughout her career, Dr. Stanimirovic has led scientific breakthroughs and internationally recognized innovations that have advanced treatments for these diseases. She has written over 190 manuscripts and book chapters. She holds 20 patents related to brain vascular physiology and drug delivery across the blood brain barrier.

Note: Dr. Danica Stanimirovic (1962 – 2024) revolutionized the scientific community's understanding of brain function and diseases. She is greatly missed, but forever remembered for her life's work developing technologies to overcome the blood-brain barrier to help deliver therapeutics to the brain and ultimately treat such neurological diseases as brain cancer, Alzheimer's and dementia.